SANA News
Archived Headlines
- Cell therapy biotech Sana Biotechnology increases deal size by 60% ahead of $517 million IPO 02/03/21
- US IPO Week Ahead: Canadian IT and German chemicals lead a diverse 9 IPO week 01/29/21
- Cell therapy biotech Sana Biotechnology sets terms for $323 million IPO 01/28/21
- Cell therapy biotech Sana Biotechnology files for a $150 million IPO 01/13/21
US IPO Week Ahead: Health insurer Oscar Health leads a 2 IPO week
Two IPOs are scheduled to raise $1.3 billion in the week ahead. While the IPO calendar is relatively quiet at the moment, several issuers could launch, including pool equipment supplier Hayward Holdings (HAYW) and crafts-focused...read more
US IPO Weekly Recap: Biotechs flood the IPO market in a 14 IPO week
The IPO market had its busiest week yet this year with 14 IPOs raising $3.9 billion and 27 SPACs raising $9.2 billion. The IPO pipeline remained active as well, with 3 IPOs and 38 SPACs submitting initial filings. ...read more
Cell therapy biotech Sana Biotechnology prices further upsized IPO at $25, above the upwardly revised range
Sana Biotechnology, a preclinical biotech developing engineered cell therapies for multiple indications, raised $588 million by offering 23.5 million shares at $25, above upwardly revised the range of $23 to $24. The company offered 1.5 million more shares than...read more
February starts off with the busiest week for US IPOs in over a decade
16 IPOs are set to make this the busiest week for the US IPO market since December 2006. Driven by faster IPO timelines and momentum from last year, 2021 is positioning itself to be a banner year for the IPO market, and this latest milestone joins a growing...read more